Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ferraretti, A.P.
Right arrow Articles by Feliciani, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferraretti, A.P.
Right arrow Articles by Feliciani, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 6, 1457-1460, June 1999
© 1999 European Society of Human Reproduction and Embryology

Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety

A.P. Ferraretti1, L. Gianaroli, C. Magli, D. Fortini, H.A. Selman and E. Feliciani

S.I.S.ME.R., Reproductive Medicine Unit, Via Mazzini 12, 40138, Bologna, Italy

In a prospective randomized study, we analysed 125 patients at risk of ovarian hyperstimulation syndrome (OHSS), selected in the period between January 1996 and July 1997. All the patients had blood oestradiol concentration >=1500 pg/ml on the day of human chorionic gonadotrophin (HCG) administration and >=15 oocytes were collected. The patients were matched in two groups: group A, control group (n = 67), had fresh embryo transfers; group B (n = 58) had cryopreservation of all obtained pronucleate embryos. Pregnancy, live birth rates and the incidence of OHSS were compared between the two groups. There were no significant differences in terms of pregnancies per patient (46.3 versus 48.3%) and live birth rates (38.8 versus 39.6%). No cases of OHSS occurred in group B, while four patients developed the syndrome in group A. The implantation rate was slightly but not significantly lower in group B ({chi}2 = 1.03). These results suggest that elective cryopreservation of all zygotes might prevent the risk of OHSS in patients undergoing IVF treatment. In contrast to what has been reported by other authors, our results show that the elective cryopreservation of zygotes does not affect pregnancy and live birth rates.

Key words: cryopreservation/embryo/ovarian hyperstimulation/thawing/zygotes

1 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
C. B. Sheehan, M. Lane, and D. K. Gardner
The CryoLoop facilitates re-vitrification of embryos at four successive stages of development without impairing embryo growth
Hum. Reprod., November 1, 2006; 21(11): 2978 - 2984.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. L. Gustofson, J. H. Segars, and F. W. Larsen
Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome
Hum. Reprod., November 1, 2006; 21(11): 2830 - 2837.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M.C. Magli, L. Gianaroli, N. Grieco, E. Cefalu, G. Ruvolo, and A.P. Ferraretti
Cryopreservation of biopsied embryos at the blastocyst stage
Hum. Reprod., October 1, 2006; 21(10): 2656 - 2660.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Endo, H. Honnma, T. Hayashi, M. Chida, K. Yamazaki, Y. Kitajima, A. Azumaguchi, H. Kamiya, and R. Kudo
Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos
Hum. Reprod., October 1, 2002; 17(10): 2548 - 2551.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
U. Ulug, M. Bahceci, H. F. Erden, E. Shalev, and I. Ben-Shlomo
The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles
Hum. Reprod., February 1, 2002; 17(2): 310 - 313.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. Raziel, S. Friedler, M. Schachter, D. Strassburger, E. Mordechai, and R. Ron-El
Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome
Hum. Reprod., January 1, 2002; 17(1): 107 - 110.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
P.E. Egbase, M.A. Sharhan, P. Berlingieri, and J.G. Grudzinskas
Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment
Hum. Reprod., October 1, 2000; 15(10): 2082 - 2086.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.